**Core Concept**
Carbimazole is a prodrug that is converted to its active metabolite, methimazole, which is a thiourea derivative used in the management of hyperthyroidism. It acts by inhibiting the synthesis of thyroid hormones through the inhibition of the enzyme thyroid peroxidase (TPO).

**Why the Correct Answer is Right**
Carbimazole and its active metabolite methimazole work by binding to the thyroid peroxidase enzyme, which is essential for the iodination of tyrosine residues in thyroid hormones. This binding inhibits the coupling of iodotyrosines to form thyroxine (T4) and triiodothyronine (T3), thereby reducing the production of thyroid hormones. The inhibition of TPO also leads to the accumulation of iodine in the thyroid gland, which can cause a goiter.

**Why Each Wrong Option is Incorrect**
**Option A:**
*This option is not provided, so we cannot evaluate it.*

**Option B:** Hyperkalemia - This is incorrect because carbimazole can actually cause hypokalemia due to increased potassium excretion in the urine.

**Option C:** Hypothyroidism - This is incorrect because carbimazole is used to treat hyperthyroidism, not hypothyroidism.

**Option D:** Liver damage - This is incorrect because carbimazole is not commonly associated with liver damage, although it can cause other side effects such as agranulocytosis and hepatotoxicity.

**Clinical Pearl / High-Yield Fact**
Carbimazole can cause agranulocytosis, a potentially life-threatening condition characterized by a decrease in white blood cells. Patients taking carbimazole should be monitored regularly for signs of agranulocytosis, such as fever, sore throat, and fatigue.

**Correct Answer:** D.